|
| |
| | | 67952 | | 04.08.2020 | | Pfizer AG | | | | | | | 03.08.2025 | | | | | | | | 05.01.2021 | | 07.16.10. | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ruxience 100 mg/10 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Rituximab 100mg / 10ml) | L01XC02 | | | 02 | Ruxience 500 mg/50 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Rituximab 500mg / 50ml) | L01XC02 | |
|
|
|
